The American Academy of Otolaryngic Allergy - AAOA

11/25/2025

The Explorers Course 2026: Surgical & Medical Management of Airway Disease in Otolaryngology will kick off on Thursday, January 22 at 4:30 pm with the New Demo Labs and will conclude on Saturday, January 24 at 12:20 pm. Learn More:

The Education Committee is reimagining our course curriculum to offer content better aligned with your practice. Focusing on surgical and medical management ...

11/21/2025

The Dangerous Benadryl Trend Putting Young People at Risk

https://www.aaoallergy.org/the-dangerous-benadryl-trend-putting-young-people-at-risk/

The trend documented in the recent Wired article — where adolescents intentionally take dangerously high doses of diphenhydramine (Benadryl) to provoke hallucinations — is not just reckless, but medically perilous. Read More

11/20/2025

The US FDA approves an oral pill for use in adult patients with chronic spontaneous urticaria/CSU whose symptoms persist despite treatment with H1 antihistamines:

Novartis (NYSE:NVS) is one of the best growth stocks to buy now. On September 30, Novartis announced the US FDA approval of its drug, Rhapsido (remibrutinib).

11/11/2025

10/31/2025

No tricks here - the AAOA Annual Meeting registration is free for members in good standing — and we’re excited to see you next month! Still need to register? https://www.aaoallergy.org/education/aaoa-annual-meeting-2025/

Join us at the hybrid 2025 AAOA Annual Meeting. Experience Business of Medicine, research, latest on ENT allergy, biologics, and more. Register Today

10/23/2025

FDA Approves TEZSPIRE® For Chronic Rhinosinusitis With Nasal Polyps: https://wwwext.amgen.com/newsroom/press-releases/2025/10/fda-approves-tezspire-for-chronic-rhinosinusitis-with-nasal-polyps

, /PRNewswire/ -- (NASDAQ:AMGN) and AstraZeneca today announced that the (FDA) approved TEZSPIRE® (tezepelumab-ekko) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in adult and pediatric patients aged 12 years and older. TEZSPIRE is...

10/23/2025

Pediatric Food-Related Adverse Events Surge as Food Labeling Falls Short:

CAERS reports reveal a 15.5-fold increase in serious adverse food- and supplement-related events in youth since 2004.

10/22/2025

A newly developed score called MiDAS helps clinicians quantify how multiple comorbidities impact severe or hard‑to‑treat asthma, enabling a more holistic treatment approach beyond just airway‑focused care. https://www.medscape.com/viewarticle/q-can-new-tool-help-tough-asthma-cases-2025a1000sc9?ecd=WNL_trdalrt_pos1_251021_etid7815897&uac=81001SX&impID=7815897

The new tool, available as a phone app, helps identify comorbidities and produces a score to guide clinicians.

10/21/2025

Multiple Nut Allergies May Predict Anaphylaxis Risk in Children: https://www.medscape.com/viewarticle/multiple-nut-allergies-may-predict-anaphylaxis-risk-children-2025a1000p1k?ecd=mkm_ret_251017_mscpmrk_allergy_ped-allergy_etid7802460&uac=81001SX&impID=7802460

A Turkish study finds that multiple nut allergies are associated with a higher risk for anaphylaxis in children.

10/21/2025

Fall is the perfect time to slow down, savor the season, and make sure you’ve checked off everything on your to-do list. Here are a few essentials to help you make the most of it:

~Visit a local fall festival, farm, or orchard

~Treat yourself to something pumpkin-flavored—coffee, pie, or even something homemade

~Pack for Oceanside, CA to attend the 2025 AAOA Annual Meeting, November 14-16. Learn More: https://www.aaoallergy.org/education/aaoa-annual-meeting-2025/

~Take a scenic walk or drive to see the fall foliage

~Register for the Explorers Course 2026: Surgical & Medical Management of Airway Disease in Otolaryngology

~Book your hotel room at the Fairmont Sonoma Mission Inn & Spa, Sonoma, CA for the Explorers Course 2026

~Spend some quality time with your loved ones

Fall may be fleeting, but there’s still time to enjoy it all—and stay on top of what’s ahead.

10/16/2025

Overnight, CMS issued updated guidance to Medicare Administrative Contractors (MACs) instructing them to limit the Medicare claims hold for services provided on or after October 1, 2025, that are impacted by the expired Medicare legislative payment provisions, including telehealth services other than for behavioral or mental health care, and services provided in locations with a work geographic practice cost index (GPCI) below the 1.0 floor. For all other services, Medicare claims will continue to be processed and paid in a timely manner. To date, no payments have been delayed as statute already requires all claims to be held for a minimum of 14 days.

The AMA continues to monitor the impact of the government shutdown, and any impacted physicians are encouraged to email AMA advocacy staff at ama.advocacy@ama-assn.org and include the subject heading “Medicare Payment Delay.”

Please note that CMS has also updated its telehealth FAQs.

https://www.cms.gov/medicare/payment/fee-for-service-providers

A List of All Fee-For-Service Providers

10/13/2025

Adding Allergy to Your Practice Educational Stack provides basic content to allow you to understand how to get started with practicing clinical allergy.

This stacks offers up to 6 hrs of CME | CC eligible. Learn more: https://www.aaoallergy.org/education/aaoa-educational-stack-2024-adding-allergy-to-your-practice/

Register today for the AAOA Educational Stack 2024 - Adding Allergy To Your Practice. This new virtual learning Opportunity is a great way to augment your AAOA education, train your staff, earn CME, or refresh. Learn More